Christopher W. Fulton

Array ( [id] => 6276502 [patent_doc_number] => 20020106767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Site-specific protein modification' [patent_app_type] => new [patent_app_number] => 09/972016 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5522 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106767.pdf [firstpage_image] =>[orig_patent_app_number] => 09972016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6209970 [patent_doc_number] => 20020072500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Hydroxy acid integrin antagonists' [patent_app_type] => new [patent_app_number] => 09/963927 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16666 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072500.pdf [firstpage_image] =>[orig_patent_app_number] => 09963927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1453822 [patent_doc_number] => 06462022 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Lisinopril compositions having large-particle DCPD' [patent_app_type] => B1 [patent_app_number] => 09/962429 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3733 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462022.pdf [firstpage_image] =>[orig_patent_app_number] => 09962429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801578 [patent_doc_number] => 20030096743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'p-Amidobenzylethers in drug delivery agents' [patent_app_type] => new [patent_app_number] => 09/963103 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16097 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096743.pdf [firstpage_image] =>[orig_patent_app_number] => 09963103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261749 [patent_doc_number] => 20020187926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Combined use of derivatives of GLP-1 analogs and PPAR ligands' [patent_app_type] => new [patent_app_number] => 09/951300 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5309 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187926.pdf [firstpage_image] =>[orig_patent_app_number] => 09951300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504700 [patent_doc_number] => 06465615 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Monohydrate lisinopril' [patent_app_type] => B1 [patent_app_number] => 09/950467 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6421 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465615.pdf [firstpage_image] =>[orig_patent_app_number] => 09950467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575072 [patent_doc_number] => 06468976 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Monohydrate lisinopril' [patent_app_type] => B1 [patent_app_number] => 09/950472 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6424 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468976.pdf [firstpage_image] =>[orig_patent_app_number] => 09950472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745633 [patent_doc_number] => 20030022816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Combined use of derivatives of GLP-1 analogs and PPAR ligands' [patent_app_type] => new [patent_app_number] => 09/949344 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5285 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022816.pdf [firstpage_image] =>[orig_patent_app_number] => 09949344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 277762 [patent_doc_number] => 07556835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'High efficiency protein extraction' [patent_app_type] => utility [patent_app_number] => 10/363612 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7735 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/556/07556835.pdf [firstpage_image] =>[orig_patent_app_number] => 10363612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243447 [patent_doc_number] => 20020045734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Novel reovirus-derived proteins and uses therefor' [patent_app_type] => new [patent_app_number] => 09/943002 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8660 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045734.pdf [firstpage_image] =>[orig_patent_app_number] => 09943002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6382704 [patent_doc_number] => 20020120099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Novel cyclic tetrapeptide derivatives and pharmaceutical uses thereof' [patent_app_type] => new [patent_app_number] => 09/945237 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12426 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20020120099.pdf [firstpage_image] =>[orig_patent_app_number] => 09945237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7622209 [patent_doc_number] => 06977292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-20 [patent_title] => 'Nucleophile-stable thioester generating compounds, methods of production and use' [patent_app_type] => utility [patent_app_number] => 10/332454 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9771 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977292.pdf [firstpage_image] =>[orig_patent_app_number] => 10332454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721292 [patent_doc_number] => 20030054981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Echinocandin pharmaceutical formulations containing micelle-forming surfactants' [patent_app_type] => new [patent_app_number] => 09/942431 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11010 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054981.pdf [firstpage_image] =>[orig_patent_app_number] => 09942431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478526 [patent_doc_number] => 20020022747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-21 [patent_title] => 'Aminobenzoic acid derivatives having anti-tumorigenic activity, methods of making and using the same' [patent_app_type] => new [patent_app_number] => 09/941493 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10714 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20020022747.pdf [firstpage_image] =>[orig_patent_app_number] => 09941493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248397 [patent_doc_number] => 06673772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Dipeptide compounds and their use as antiviral agents' [patent_app_type] => B2 [patent_app_number] => 09/939858 [patent_app_country] => US [patent_app_date] => 2001-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 15106 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673772.pdf [firstpage_image] =>[orig_patent_app_number] => 09939858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 724942 [patent_doc_number] => 07045591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-16 [patent_title] => 'Selective cyclic peptides with melanocortin-4 receptor (MC4-R) agonist activity' [patent_app_type] => utility [patent_app_number] => 09/939966 [patent_app_country] => US [patent_app_date] => 2001-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64960 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045591.pdf [firstpage_image] =>[orig_patent_app_number] => 09939966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636295 [patent_doc_number] => 20020086828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Uses for amino acid anticonvulsants' [patent_app_type] => new [patent_app_number] => 09/938677 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15092 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086828.pdf [firstpage_image] =>[orig_patent_app_number] => 09938677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6362707 [patent_doc_number] => 20020058788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Facile deprotection of Fmoc protected amino groups' [patent_app_type] => new [patent_app_number] => 09/939455 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3745 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058788.pdf [firstpage_image] =>[orig_patent_app_number] => 09939455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1080658 [patent_doc_number] => 06835714 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-28 [patent_title] => 'Heterocyclic compounds, intermediates thereof and elastase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/913538 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14671 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835714.pdf [firstpage_image] =>[orig_patent_app_number] => 09913538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6621911 [patent_doc_number] => 20020065219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Water soluble thiazolyl peptide derivatives' [patent_app_type] => new [patent_app_number] => 09/928468 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15188 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065219.pdf [firstpage_image] =>[orig_patent_app_number] => 09928468 [rel_patent_id] =>[rel_patent_doc_number] =>)